insperity inc. - NSP
NSP
Close Chg Chg %
73.17 0.75 1.03%
Open Market
73.92
+0.75 (1.03%)
Volume: 50.01K
Last Updated:
Nov 21, 2024, 11:18 AM EDT
Company Overview: insperity inc. - NSP
NSP Key Data
| Open $72.87 | Day Range 72.53 - 74.53 |
| 52 Week Range 71.70 - 119.41 | Market Cap $2.73B |
| Shares Outstanding 37.38M | Public Float 35.37M |
| Beta 1.14 | Rev. Per Employee N/A |
| P/E Ratio 23.21 | EPS $3.21 |
| Yield 319.85% | Dividend $0.60 |
| EX-DIVIDEND DATE Sep 5, 2024 | SHORT INTEREST N/A |
| AVERAGE VOLUME 451.17K |
NSP Performance
| 1 Week | 0.03% | ||
| 1 Month | -5.66% | ||
| 3 Months | -21.82% | ||
| 1 Year | -35.70% | ||
| 5 Years | -1.07% |
NSP Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
5
Full Ratings ➔
About insperity inc. - NSP
Insperity, Inc. engages in the provision of human resources and business solutions designed to help improve business performance. The firm also offers payroll and employment administration, employee benefits, workers’ compensation, government compliance, performance management, and training and development services along with cloud-based human capital management platform. The company was founded by Paul J. Sarvadi in April 1986 and is headquartered in Kingwood, TX.
NSP At a Glance
Insperity, Inc.
19001 Crescent Springs Drive
Kingwood, Texas 77339-3802
| Phone | 1-281-358-8986 | Revenue | 6.49B | |
| Industry | Miscellaneous Commercial Services | Net Income | 171.38M | |
| Sector | Commercial Services | 2023 Sales Growth | 9.211% | |
| Fiscal Year-end | 12 / 2024 | Employees | 4,400 | |
| View SEC Filings |
NSP Valuation
| P/E Current | 23.007 |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | 26.225 |
| Price to Sales Ratio | 0.693 |
| Price to Book Ratio | 46.677 |
| Price to Cash Flow Ratio | 22.643 |
| Enterprise Value to EBITDA | 15.98 |
| Enterprise Value to Sales | 0.644 |
| Total Debt to Enterprise Value | 0.107 |
NSP Efficiency
| Revenue/Employee | 1,474,061.591 |
| Income Per Employee | 38,950.455 |
| Receivables Turnover | 9.347 |
| Total Asset Turnover | 3.067 |
NSP Liquidity
| Current Ratio | 1.111 |
| Quick Ratio | 1.111 |
| Cash Ratio | 0.533 |
NSP Profitability
| Gross Margin | 15.327 |
| Operating Margin | 3.37 |
| Pretax Margin | 3.47 |
| Net Margin | 2.642 |
| Return on Assets | 8.104 |
| Return on Equity | 195.978 |
| Return on Total Capital | 31.718 |
| Return on Invested Capital | 33.382 |
NSP Capital Structure
| Total Debt to Total Equity | 477.132 |
| Total Debt to Total Capital | 82.673 |
| Total Debt to Total Assets | 20.749 |
| Long-Term Debt to Equity | 455.966 |
| Long-Term Debt to Total Capital | 79.006 |
- Income Statement
- Balance Sheet
- Cash Flow Statement
Annual Financials for Insperity Inc. - NSP
Collapse All in section
| All values USD millions. | 2020 | 2021 | 2022 | 2023 | 5-year trend |
|---|---|---|---|---|---|
Sales/Revenue
| 4.29B | 4.97B | 5.94B | 6.49B | |
Sales Growth
| -0.64% | +16.00% | +19.42% | +9.21% | |
Cost of Goods Sold (COGS) incl D&A
| 3.51B | 4.19B | 4.97B | 5.49B | |
COGS excluding D&A
| - | - | - | - | - |
Depreciation & Amortization Expense
| 31.19M | 38.55M | 40.66M | 42.71M | |
Depreciation
| - | - | - | - | - |
Amortization of Intangibles
| - | - | - | - | - |
COGS Growth
| -2.75% | +19.37% | +18.53% | +10.54% | |
Gross Income
| 775.66M | 781.55M | 970.57M | 994.10M | |
Gross Income Growth
| +10.15% | +0.76% | +24.18% | +2.42% | |
Gross Profit Margin
| +18.09% | +15.72% | +16.34% | +15.33% |
| 2020 | 2021 | 2022 | 2023 | 5-year trend | |
|---|---|---|---|---|---|
SG&A Expense
| 580.98M | 608.23M | 720.33M | 775.55M | |
Research & Development
| - | - | - | - | - |
Other SG&A
| 580.98M | 608.23M | 720.33M | 775.55M | |
SGA Growth
| +12.25% | +4.69% | +18.43% | +7.66% | |
Other Operating Expense
| - | - | - | - | - |
Unusual Expense
| - | - | - | - | - |
EBIT after Unusual Expense
| 194.69M | 173.33M | 250.24M | 218.55M | |
Non Operating Income/Expense
| 2.60M | 2.45M | 9.39M | 33.67M | |
Non-Operating Interest Income
| 2.60M | 2.45M | 9.39M | 33.67M | |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Interest Expense
| 8.02M | 7.46M | 14.21M | 27.14M | |
Interest Expense Growth
| +4.83% | -6.96% | +90.49% | +91.01% | |
Gross Interest Expense
| 8.02M | 7.46M | 14.21M | 27.14M | |
Interest Capitalized
| - | - | - | - | - |
Pretax Income
| 189.27M | 168.32M | 245.43M | 225.08M | |
Pretax Income Growth
| -0.20% | -11.07% | +45.81% | -8.29% | |
Pretax Margin
| +4.41% | +3.38% | +4.13% | +3.47% | |
Income Tax
| 51.03M | 44.24M | 66.08M | 53.70M | |
Income Tax - Current - Domestic
| 56.68M | 39.53M | 76.72M | 58.51M | |
Income Tax - Current - Foreign
| - | - | - | - | - |
Income Tax - Deferred - Domestic
| (5.65M) | 4.71M | (10.64M) | (4.81M) | |
Income Tax - Deferred - Foreign
| - | - | - | - | - |
Income Tax Credits
| - | - | - | - | - |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Other After Tax Income (Expense)
| - | - | (782.00K) | (210.00K) | - |
Consolidated Net Income
| 137.46M | 123.87M | 179.35M | 171.38M | |
Minority Interest Expense
| - | - | - | - | - |
Net Income
| 137.46M | 123.87M | 179.35M | 171.38M | |
Net Income Growth
| -7.96% | -9.88% | +44.79% | -4.44% | |
Net Margin Growth
| +3.21% | +2.49% | +3.02% | +2.64% | |
Extraordinaries & Discontinued Operations
| - | - | - | - | - |
Discontinued Operations
| - | - | - | - | - |
Net Income After Extraordinaries
| 137.46M | 123.87M | 179.35M | 171.38M | |
Preferred Dividends
| - | - | - | - | - |
Net Income Available to Common
| 137.46M | 123.87M | 179.35M | 171.38M | |
EPS (Basic)
| 3.57 | 3.2232 | 4.7055 | 4.5331 | |
EPS (Basic) Growth
| -3.93% | -9.71% | +45.99% | -3.66% | |
Basic Shares Outstanding
| 38.50M | 38.43M | 38.12M | 37.81M | |
EPS (Diluted)
| 3.5408 | 3.1842 | 4.6444 | 4.4698 | |
EPS (Diluted) Growth
| -4.33% | -10.07% | +45.86% | -3.76% | |
Diluted Shares Outstanding
| 38.82M | 38.90M | 38.62M | 38.34M | |
EBITDA
| 225.88M | 211.88M | 290.90M | 261.26M | |
EBITDA Growth
| +4.89% | -6.20% | +37.30% | -10.19% | |
EBITDA Margin
| +5.27% | +4.26% | +4.90% | +4.03% |
Snapshot
| Average Recommendation | HOLD | Average Target Price | 103.75 | |
| Number of Ratings | 5 | Current Quarters Estimate | 0.018 | |
| FY Report Date | 12 / 2024 | Current Year's Estimate | 3.534 | |
| Last Quarter’s Earnings | 0.39 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | 5.52 | Next Fiscal Year Estimate | 3.672 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 5 | 4 | 5 | 5 |
| Mean Estimate | 0.02 | 2.02 | 3.53 | 3.67 |
| High Estimates | 0.07 | 2.26 | 3.59 | 3.90 |
| Low Estimate | -0.02 | 1.84 | 3.50 | 3.17 |
| Coefficient of Variance | 190.03 | 8.64 | 1.03 | 7.84 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 1 | 1 | 2 |
| OVERWEIGHT | 0 | 0 | 0 |
| HOLD | 3 | 3 | 2 |
| UNDERWEIGHT | 0 | 0 | 0 |
| SELL | 1 | 1 | 0 |
| MEAN | Hold | Hold | Overweight |
SEC Filings for Insperity Inc. - NSP
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Insperity Inc. - NSP
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Jun 4, 2024 | Paul J. Sarvadi Chairman of the Board & CEO; Director | 525,252 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $96.08 per share | 50,466,212.16 |
| Jun 4, 2024 | Paul J. Sarvadi Chairman of the Board & CEO; Director | 525,552 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $95.39 per share | 50,132,405.28 |
| May 24, 2024 | John L. Lumelleau Director | 11,442 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 24, 2024 | Latha Ramchand Director | 11,442 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 24, 2024 | Randall Arthur Mehl Director | 18,029 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 24, 2024 | Carol Rose Kaufman Director | 39,389 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 24, 2024 | John M. Morphy Director | 10,933 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 24, 2024 | Ellen H. Masterson Director | 14,857 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 24, 2024 | Eli Jones Director | 7,965 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 24, 2024 | Timothy T. Clifford Director | 18,299 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 24, 2024 | Richard G. Rawson Director | 3,743 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 13, 2024 | Douglas S. Sharp EVP Finance, CFO & Treasurer | 28,516 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $104.47 per share | 2,979,066.52 |
| Mar 5, 2024 | Arthur Steve Arizpe President and COO | 77,660 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $100.29 per share | 7,788,521.40 |
| Mar 5, 2024 | Arthur Steve Arizpe President and COO | 78,551 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 5, 2024 | James D. Allison EVP, Comp Benefits Solns & CPO | 50,769 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $100.29 per share | 5,091,623.01 |
| Mar 5, 2024 | Douglas S. Sharp EVP Finance, CFO & Treasurer | 33,728 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 5, 2024 | James D. Allison EVP, Comp Benefits Solns & CPO | 51,218 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 5, 2024 | Paul J. Sarvadi Chairman of the Board & CEO; Director | 537,435 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 4, 2024 | Arthur Steve Arizpe President and COO | 73,272 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $97.34 per share | 7,132,296.48 |
| Mar 4, 2024 | Christian P. Callens SVP Legal, Gen Counsel & Sec | 8,791 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |